Oncology & Cancer

Managing ovarian cancer risk in women with BRCA1/2 genetic variants

BRCA1 and BRCA2 genetic variants are a clinically important risk factor for the development of ovarian and breast cancer, and women who carry these variants have a lifetime risk of ovarian cancer of 39%-44% and 11%-17%, respectively.

Oncology & Cancer

Researchers make next move in the fight against ovarian cancer

Ovarian cancer claims the highest mortality rate of all gynecologic cancers, as high as 70 percent—in part because the disease is rarely detected earlier than stage 3 or 4. When the disease is discovered early in its development, ...

Obstetrics & gynaecology

Essure female sterilization device appears safe: study

(HealthDay)—Essure implants used in female sterilization have come under fire in recent years, with women reporting a wide array of problems to the U.S. Food and Drug Administration.

page 1 from 9